SCHEMBL862569

SCHEMBL862569

C/N=C\N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL217711 1.00
SCHEMBL217712 1.00
Hydrochloric Acid SCHEMBL7058804 0.96
Hydrochloric Acid SCHEMBL7058803 0.96
SCHEMBL19685884 0.75
SCHEMBL31231602 0.70 ALOX15 (0.33)
SCHEMBL563340 0.70 ALOX15 (0.33)
SCHEMBL14556333 0.70 ALOX15 (0.33)
SCHEMBL563339 0.70 ALOX15 (0.33)
SCHEMBL1528792 0.70 ALOX15 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10906921-B2 Base generator, reagent, organic salt, composition, method for manufacturing device, cured film and device TOYO GOSEI CO., LTD. (JP) 2021-02-02 US disclosed
US-10611732-B2 HIV replication inhibiting pyrimidines JANSSEN PHARMACEUTICA NV (BE) 2020-04-07 US disclosed
EP-2298761-B1 HIV INHIBITING PYRIMIDINES DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2020-03-25 EP disclosed
US-20190330247-A1 BASE GENERATOR, REAGENT, ORGANIC SALT, COMPOSITION, METHOD FOR MANUFACTURING DEVICE, CURED FILM AND DEVICE TOYO GOSEI CO., LTD. (JP) 2019-10-31 US disclosed
US-20190322628-A1 HIV REPLICATION INHIBITING PYRIMIDINES JANSSEN PHARMACEUTICA NV (BE) 2019-10-24 US disclosed
US-10370340-B2 HIV replication inhibiting pyrimidines JANSSEN PHARMACEUTICA NV (BE) 2019-08-06 US disclosed
US-9981919-B2 HIV replication inhibiting pyrimidines JANSSEN PHARMACEUTICAL N.V. (BE) 2018-05-29 US disclosed
US-9981919-B2 HIV replication inhibiting pyrimidines JANSSEN PHARMACEUTICAL N.V. (BE) 2018-05-29 US disclosed
US-20170355708-A1 POTASSIUM CHANNEL MODULATORS CADENT THERAPEUTICS, INC. 2017-12-14 US disclosed
US-20170320835-A1 HIV REPLICATION INHIBITING PYRIMIDINES JANSSEN PHARMACEUTICA NV (BE) 2017-11-09 US disclosed
US-20110218185-A1 AZOLOTRIAZINONE MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS SYNGENE INTERNATIONAL LIMITED (IN) 2011-09-08 US disclosed
US-20110184188-A1 Insecticidal Benzenedicarboxamide Derivative BAYER CROPSCIENCE AG (DE) 2011-07-28 US disclosed
US-7700666-B2 Composition containing a prepolymer and a crosslinker, process for producing and use thereof 3M ESPE AG (DE) 2010-04-20 US disclosed
US-7691923-B2 Curable and cured wood particle composites and method of making same ROHM AND HAAS COMPANY (US) 2010-04-06 US disclosed
US-20100004234-A1 SPECIFIC KINASE INHIBITORS KOSAN BIOSCIENCES INCORPORATED 2010-01-07 US disclosed
EP-2006289-A1 PYRAZOLE-TYPE CYANINE DYE Wako Pure Chemical Industries, Ltd. (JP) 2008-12-24 EP disclosed
US-20080287572-A1 Curable and cured wood particle composites and method of making same ROHM AND HAAS COMPANY 2008-11-20 US disclosed
WO-2007056468-A1 METHODS FOR INHIBITING PROTEIN KINASES SCHERING CORPORATION (US) 2007-05-18 WO disclosed
US-20070051922-A1 Polymer light-emitting material and polymer light-emitting device SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-03-08 US disclosed
US-20070051922-A1 Polymer light-emitting material and polymer light-emitting device SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-03-08 US disclosed